CBRX Insider Trading Activity and SEC Form 4 Filings
CBRX insider trading summary
No open-market insider purchases or sales of Columbia Laboratories Inc (CBRX) have been reported on SEC Form 4 in the past 12 months.
Latest CBRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 20, 2014 | Donald H Hunter | Director | Buy | $6K (1,000 @ $5.98) |
| Aug 13, 2014 | Frank Condella Jr | President & CEO | Buy | $60K (10,000 @ $5.98) |
| May 5, 2014 | Frank Condella Jr | President & CEO | Buy | $67K (10,000 @ $6.65) |
| Mar 7, 2014 | Actavis plc | 10% Owner | Sell | $8.1M (1,400,000 @ $5.76) |
| Mar 7, 2014 | Coventry Acquisition, LLC | 10% Owner | Sell | $8.1M (1,400,000 @ $5.76) |
| Nov 26, 2013 | Jones Jonathan Brian Lloyd | Vice President & CFO | Buy | $10K (1,580 @ $6.32) |
| Nov 26, 2013 | Frank Condella Jr | President & CEO | Buy | $32K (5,000 @ $6.32) |
| May 15, 2013 | Frank Condella Jr | President & CEO | Buy | $51K (80,000 @ $0.63) |
| May 14, 2013 | Jones Jonathan Brian Lloyd | Vice President & CFO | Buy | $5K (8,000 @ $0.63) |
| Mar 15, 2010 | Frank Condella Jr | Interim CEO | Buy | $112K (100,000 @ $1.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.